Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 6, 2018.
Article Versions
- previous version (July 20, 2018 - 14:19).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2018
Author Information
- 1Virology Department, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany; and
- 2Process Virology, Genentech, 1 DNA Way South San Francisco, CA 94080, USA
- ↵* Corresponding Author: Virology Department, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany; e-mail: Astrid.Schwantes{at}pei.de
Cited By...
Jump to section
- Article
- Abstract
- Background and Session Overview
- Retrovirus Clearance Risk Evaluation and Clearance Target for Chinese Hamster Ovary Cells
- Bin Yang, Genentech
- A Proposal for Future BLA Submissions on Virus Filtration: Parvovirus Removal Studies Only
- Rachel Specht and Qi Chen, Genentech
- qPCR as an Alternative to TEM and Infectivity Assays
- William Rayfield, Merck
- The Use of RVLP in Research and Development Viral Clearance Studies
- Moritz Bennecke, Roche Pharma
- Getting Medicines to Patients Fast
- Sherrie Curtis, Genetech
- Streamlining Virus Clearance (VC) Studies to Reduce Costs and Time to Clinic
- Lisa Connell-Crowley, Just Biotherapeutics
- Viral Clearance Strategy for Early-Phase Program
- Mi Jin, Teva Pharmaceuticals
- ASTM Update on Standards for Low pH Inactivation and Virus Retentive Filtration
- John Schreffler, Janssen J&J
- Summary
- Conflict of Interest Declaration
- Reference
- Figures & Data
- References
- Info & Metrics